Shigeo Ichihashi/LinkedIn
Oct 18, 2025, 05:13
The CLARIFY IMA Study From Shigeo Ichihashi and Colleagues was Recently Published!
Vascular News shared Shigeo Ichihashi’s and colleagues latest study on LinkedIn:
“Results from a multicentre randomised controlled trial indicate that pre-emptive inferior mesenteric artery (IMA) embolisation during endovascular aneurysm repair (EVAR) does not significantly reduce aneurysm sac volume or rates of type II endoleak.
The CLARIFY IMA study from Shigeo Ichihashi (Nara Medical University, Nara, Japan) and colleagues was recently published in the European Journal of Vascular and Endovascular Surgery (EJVES) and presented at the 39th European Society for Vascular Surgery annual meeting (23–26 September, Istanbul, Türkiye).”
Read more here.
Stay updated about IMA latest news with Hemostasis Today.
-
Sep 30, 2026, 15:58Bernhard Merget: New Frontiers in Thrombosis and Stroke Research
-
Sep 30, 2026, 15:39Ifeanyichukwu Ifechidere: The Molecular Orchestra of Primary Hemostasis
-
Sep 30, 2026, 15:28Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
-
Sep 30, 2026, 15:07Chiranjeev Sharma: Targeting Factor XIa with the Synthetic Inhibitor SB-01
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?